Breast Cancer

, Volume 25, Issue 5, pp 619–625 | Cite as

LncRNA PlncRNA-1 overexpression inhibits the growth of breast cancer by upregulating TGF-β1 and downregulating PHGDH

  • Qing Li
  • Haifeng Gao
  • Shuyan Zhou
  • Yuting Liao
Rapid Communication



To investigate the role of lncRNA PlncRNA-1 in the pathogenesis of breast cancer.


A total of 78 patients with breast cancer as well as 48 healthy females were included in this study. Expression in tumor tissues and adjacent healthy tissues of breast cancer patients, as well as in breast tissues and serum of both patients and healthy control was detected by qRT-PCR. Cell proliferation was detected by CCK-8 assay, and cell apoptosis was tested by MTT assay. PlncRNA-1 overexpression cell lines were constructed and the effects on TGF-β1 as well as phosphoglycerate dehydrogenase (PHGDH) were explored by western blot.


Expression levels of PlncRNA-1 were significantly lower in tumor tissues than those in adjacent healthy tissues. Significantly lower expression levels of PlncRNA-1 were also found in breast cancer patients than those in healthy controls in both breast tissue and serum. Upregulation of PlncRNA-1 promoted the expression of TGF-β1, but inhibited the expression of PHGDH. LncRNA PlncRNA-1 overexpression reduced the proliferation rate, but increased the apoptosis rate of breast cancer cells, while treatment with TGF-β inhibitor reduced those effects of PlncRNA-1 overexpression.


LncRNA PlncRNA-1 overexpression inhibits the growth of breast cancer by upregulating TGF-β1 and downregulating PHGDH.


Breast cancer PlncRNA-1 TGF-β1 Phosphoglycerate dehydrogenase 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Holohan C, Van Schaeybroeck S, Longley DB, et al. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13(10):714–26.CrossRefPubMedGoogle Scholar
  2. 2.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMedGoogle Scholar
  3. 3.
    Ellis LM, Hicklin D. Resistance to targeted therapies: refining anticancer therapy in the era of molecular oncology. Clin Cancer Res. 2009;15:7471–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Shah NS. Increasing drug resistance in extensively drug-resistant tuberculosis, South Africa. Emerg Infect Dis J CDC. 2011;17(3):510–3.Google Scholar
  5. 5.
    Yang X, Gao L, Guo X, et al. A network based method for analysis of lncRNA-disease associations and prediction of lncRNAs implicated in diseases. PLoS One. 2014;9(1):e87797.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Cui Z, Ren S, Lu J, et al. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. In: Urologic oncology: seminars and original investigations. Elsevier, 2013, vol. 31, no. 7, pp. 1117–23.Google Scholar
  7. 7.
    Wang CM, Wu QQ, Li SQ, et al. Upregulation of the long non-coding RNA PlncRNA-1 promotes esophageal squamous carcinoma cell proliferation and correlates with advanced clinical stage. Dig Dis Sci. 2014;59(3):591–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Li J, Ballim D, Rodriguez M, et al. The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3. J Biol Chem. 2014;289(51):35633–43.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Jeon WK, Choi J, Park SJ, et al. The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region. Oncotarget. 2015;6(39):41650.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Dong L, Ni J, Hu W, et al. Upregulation of long non-coding RNA plncRNA-1 promotes metastasis and induces epithelial-mesenchymal transition in hepatocellular carcinoma. Cell Physiol Biochem. 2016;38(2):836–46.CrossRefPubMedGoogle Scholar
  11. 11.
    Xu N, Chen F, Wang F, et al. Clinical significance of high expression of circulating serum lncRNA RP11-445H22. 4 in breast cancer patients: a Chinese population-based study. Tumor Biology. 2015;36(10):7659–65.CrossRefPubMedGoogle Scholar
  12. 12.
    Antonello J, Chudziak J, Redfern A, et al. An evaluation of DNA and RNA based blood biomarkers in prostate cancer. Cancer Res. 2017;77(13 Supplement):5685.
  13. 13.
    Bae MS, Moon WK, Chang JM, et al. Breast cancer detected with screening US: reasons for nondetection at mammography. Radiology. 2014;270(2):369–77.CrossRefPubMedGoogle Scholar
  14. 14.
    Grammatikakis I, Panda AC, Abdelmohsen K, et al. Long noncoding RNAs (lncRNAs) and the molecular hallmarks of aging. Aging (Albany NY). 2014;6(12):992.CrossRefGoogle Scholar
  15. 15.
    Wang J, Qiu M, Xu Y, et al. Long noncoding RNA CCAT2 correlates with smoking in esophageal squamous cell carcinoma. Tumor Biology. 2015;36(7):5523–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Mayfield RD. Emerging roles for ncRNAs in alcohol use disorders. Alcohol. 2017;60:31–9.Google Scholar
  17. 17.
    Bao M, Luo H, Chen L, et al. Impact of high fat diet on long non-coding RNAs and messenger RNAs expression in the aortas of ApoE (−/−) mice. Sci Rep. 2016;6:34161.Google Scholar
  18. 18.
    Si Y, Bai J, Wu J, et al. LncRNA PlncRNA-1 regulates proliferation and differentiation of hair follicle stem cells through TGF-β1-mediated Wnt/β-catenin signal pathway. Mol Med Rep. 2018;17(1):1191–7.PubMedGoogle Scholar
  19. 19.
    Christofk HR, Vander Heiden MG, Harris MH, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008;452(7184):230–3.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Breast Cancer Society 2018

Authors and Affiliations

  • Qing Li
    • 1
  • Haifeng Gao
    • 2
  • Shuyan Zhou
    • 3
  • Yuting Liao
    • 4
  1. 1.Department of PathologyThe People’s Hospital of DongyingDongyingChina
  2. 2.Department of OncologyThe People’s Hospital of DongyingDongyingChina
  3. 3.Department of PathophysiologyWannan Medical CollegeWuhuChina
  4. 4.Department of PathologyThe People’s Hospital of DongguanDongguanChina

Personalised recommendations